期刊文献+

乳腺癌高危人群的化学预防 被引量:5

原文传递
导出
摘要 乳腺癌是女性最常见的恶性肿瘤,其防控形势非常严峻。据估计,美国2014年有235 030例新发浸润性乳腺癌,40 430例女性死于乳腺癌[1]。在中国,乳腺癌居女性恶性肿瘤发病率的第1位、死亡原因的第5位,每年大约有21万女性患乳腺癌,约5.5万女性死于乳腺癌[2]。1乳腺癌高危人群化学预防的循证医学证据近年来,临床试验证实服用药物可以预防乳腺癌的发生。
出处 《中华乳腺病杂志(电子版)》 CAS CSCD 2015年第3期210-213,共4页 Chinese Journal of Breast Disease(Electronic Edition)
  • 相关文献

参考文献31

  • 1Siegel R, Ma J, ZouZ,et al. Cancer statistics,2014[ J]. CACancer J Clin, 2014,64(1):9-29.
  • 2陈万青,张思维,曾红梅,郑荣寿,邹小农,赵平,吴良有,李光琳,赫捷.中国2010年恶性肿瘤发病与死亡[J].中国肿瘤,2014,23(1):1-10. 被引量:882
  • 3Cuzick J, Sestak I,Bonanni B, et al. Selective oestrogenreceptor modulators in prevention of breast cancer : an updatedmeta-analysis of individual participant data[ J]. Lancet, 2013,381(9880):1827-1834.
  • 4Goss PE, Ingle JN, Al6s-Martlnez JE, et al. Exemestane forbreast-cancer prevention in postmenopausal women [ J ]. N EnglJ Med, 2011,364(25) :2381-2391.
  • 5Cuzick J, Sestak I, Forbes JF, et al. Anastrozole for preventionof breast cancer in high-risk postmenopausal women (IBIS- H ):an international, double-blind, randomised placebo-controlledtrial[J]. Lancet,2014,383(9922) : 1041-1048.
  • 6Moyer VA, U.S. Preventive Services Task Force. Medicationsto decrease the risk for breast cancer in women:recommendations from the U. S. Preventive Services Task Forcerecommendation statement [J]. Ann Intern Med, 2013,159(10):698-708.
  • 7Visvanathan K, Hurley P, Bantug E, et al. Use ofpharmacologic interventions for breast cancer risk reduction :American Society of Clinical Oncology clinical practiceguideline[J]. J Clin Oncol,2013,31(23) =2942-2962.
  • 8National Comprehensive Cancer Network. Breast cancer riskreduction ( version 1. 2014) . NCCN clinical practice guidelinesin oncology[ EB/OL]. [2015-01-20]. http//www. nccn. org.
  • 9Waters EA, McNeel TS, Stevens WM, et al. Use of tamoxifenand raloxifene for breast cancer chemoprevention in 2010 [ J].Breast Cancer Res Treat, 2012,134(2) :875-880.
  • 10Freedman AN, Graubard BI, Rao SR,et al. Estimates of thenumber of US women who could benefit from tamoxifen forbreast cancer chemoprevention [ J ]. J Natl Cancer Inst, 2003 ,95(7):526-532.

二级参考文献39

  • 1何嵘,阳爱云.中国女性乳腺癌危险因素研究现状[J].实用预防医学,2006,13(6):1669-1672. 被引量:31
  • 2左文述.女性乳腺癌危险因素的研究现状[J].中华肿瘤防治杂志,2001,12(z1):27-39. 被引量:2
  • 3王启俊,祝伟星,邢秀梅.北京城区女性乳腺癌发病死亡和生存情况20年监测分析[J].中华肿瘤杂志,2006,28(3):208-210. 被引量:81
  • 4陈建国,朱健,张永辉.启东市1972~2000年主要恶性肿瘤生存率分析[J].中国肿瘤,2006,15(9):575-578. 被引量:33
  • 5全国肿瘤防治研究办公室 卫生部卫生统计信息中心.中国试点市、县恶性肿瘤的发病与死亡(1993-1997)[M].北京:中国医药科技出版社,2002..
  • 6赵平,陈万青,孔灵芝.中国癌症发病与死亡2003-2007[M].北京:军事医学科学出版社,2012:79-90.
  • 7Freedman GM, Anderson PR, Goldstein I3 et al. Routine mammograpby is associated with earlier stage disease and greater eligibility for breast conservation in breast carcifioma patients age 40 years and older [ J ] . Cancer, 2003, 98 (5) : 918.
  • 8Gail MH, Brinton LA, Byar DP et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually [ J] . J Natl Cancer Inst, 1989, 81 (24): 1879.
  • 9Gall MH, Costantino JP, Bryant J et al. Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer [J] . J Natl Cancer Inst, 1999, 91 (21) : 1829.
  • 10国家癌症中心,卫生部疾病预防控制局.2012中国肿瘤登记年报[M].北京:军事医学科学出版社,2012.30.

共引文献2214

同被引文献21

引证文献5

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部